- Home
- Products
- Customized FluoroAb™
- ITGAE
- Anti-ITGAE MAb (Clone 2)-iFluor® 555 Succinimidyl Ester
Anti-ITGAE MAb (Clone 2)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16433)
- TARGET
- ANTIBODY
- DYE
- Name
- ITGAE
- Overview
- Humanized Anti-ITGAE IgG1-kappa (Clone 2)
- Species Reactivity
- Human
- Name
- iFluor® 555 Succinimidyl Ester
- Color
- Yellow
- Excitation⁄Emission (nm)
- 557/570
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS16433. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-533 | Anti-ITGAE-Mc-MMAF ADC-1 | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-534 | Anti-ITGAE-MCC-DM1 ADC-1 | Mcc (Maleimidomethyl cyclohexane-1-carboxylate) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-532 | Anti-ITGAE-Mc-VC-PABC-MMAE ADC-1 | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE (Monomethyl auristatin E) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-Rabies Virus Glycoprotein MAb (Clone 3)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS6169)
- Anti-CXCR4 MAb (Clone 1)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11188)
- Anti-FcRH5 MAb (Clone 6)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5570)
- Galiximab-iFluor 594 (CAT#: ADC-FL-908)
- Anti-CD33 MAb (Clone 12)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10096)
- Anti-CD2 MAb (Clone 6)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8793)
- Galiximab-iFluor 680 (CAT#: ADC-FL-910)
- Anti-FcRH5 MAb (Clone 1)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS9536)
- Anti-CD33 MAb (Clone 2)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS12601)
- Anti-CD22 MAb (Clone 23)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8502)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
